Telemus Capital’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-43,785
| Closed | -$3.02M | – | 378 |
|
|
2019
Q1 | $3.02M | Buy |
43,785
+28,086
| +179% | +$1.94M | 0.23% | 95 |
|
|
2018
Q4 | $937K | Sell |
15,699
-15,317
| -49% | -$914K | 0.08% | 192 |
|
|
2018
Q3 | $3.59M | Sell |
31,016
-71
| -0.2% | -$8.23K | 0.27% | 81 |
|
|
2018
Q2 | $3.92M | Buy |
31,087
+142
| +0.5% | +$17.9K | 0.3% | 71 |
|
|
2018
Q1 | $3.35M | Buy |
30,945
+5,706
| +23% | +$618K | 0.27% | 78 |
|
|
2017
Q4 | $2.77M | Sell |
25,239
-1,500
| -6% | -$164K | 0.21% | 93 |
|
|
2017
Q3 | $2.64M | Sell |
26,739
-752
| -3% | -$74.2K | 0.3% | 68 |
|
|
2017
Q2 | $2.78M | Buy |
27,491
+889
| +3% | +$90K | 0.28% | 71 |
|
|
2017
Q1 | $3.07M | Sell |
26,602
-1,808
| -6% | -$209K | 0.32% | 64 |
|
|
2016
Q4 | $3.41M | Buy |
28,410
+5,893
| +26% | +$707K | 0.46% | 55 |
|
|
2016
Q3 | $2.53M | Buy |
22,517
+7,538
| +50% | +$847K | 0.28% | 72 |
|
|
2016
Q2 | $1.86M | Buy |
14,979
+278
| +2% | +$34.4K | 0.23% | 93 |
|
|
2016
Q1 | $1.65M | Buy |
14,701
+3,493
| +31% | +$393K | 0.27% | 87 |
|
|
2015
Q4 | $1.22M | Buy |
11,208
+1,837
| +20% | +$200K | 0.33% | 67 |
|
|
2015
Q3 | $935K | Buy |
9,371
+820
| +10% | +$81.8K | 0.24% | 66 |
|
|
2015
Q2 | $975K | Buy |
8,551
+200
| +2% | +$22.8K | 0.25% | 65 |
|
|
2015
Q1 | $873K | Buy |
+8,351
| New | +$873K | 0.21% | 68 |
|